Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that the U.S. FDA has granted Fast Track designation for KRX-0401 (perifosine), the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE